Risk of Thyroid Cancer in Euthyroid Asymptomatic Patients with Thyroid Nodules with an Emphasis on Family History of Thyroid Cancer

다국어 초록 (Multilingual Abstract)

Objective: To determine the factors associated with thyroid cancer, focusing on first-degree family history and ultrasonography (US) features, in euthyroid asymptomatic patients with thyroid nodules.
Materials and Methods: This retrospective study included 1310 thyroid nodules of 1254 euthyroid asymptomatic patients who underwent US-guided fine-needle aspiration biopsy between November 2012 and August 2013. Nodule size and clinical risk factors–such as patient age, gender, first-degree family history of thyroid cancer, multiplicity on US and serum thyroid stimulating hormone (TSH) levels–were considered together with US features to compare benign and malignant nodules. Multiple logistic regression analysis was performed to assess the risk of thyroid malignancy according to clinical and US characteristics.
Results: Although all of the clinical factors and US findings were significantly different between patients with benign and malignant nodules, a solitary lesion on US (p = 0.041–0.043), US features and male gender (p < 0.001) were significant independent risk factors for thyroid malignancy in a multivariate analysis. Patient age, a first-degree family history of thyroid cancer and high normal serum TSH levels did not independently significantly increase the risk of thyroid cancer. However, multicollinearity existed between US assessment and patient age, first-degree family history of thyroid cancer and serum TSH values.
Conclusion: Ultrasonography findings should be the primary criterion used to decide the management of euthyroid asymptomatic patients with thyroid nodules. The concept of first-degree family history as a risk factor for thyroid malignancy should be further studied in asymptomatic patients.

참고문헌 (Reference)

1 Park YJ, "The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases" 22 : 356-362, 2012

2 McCall A, "The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters" 100 : 1128-1132, 1986

3 Jonklaas J, "The impact of age and gender on papillary thyroid cancer survival" 97 : E878-E887, 2012

4 Papini E, "Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features" 87 : 1941-1946, 2002

5 Dal Maso L, "Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors" 20 : 75-86, 2009

6 American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer" 19 : 1167-1214, 2009

7 Vriens MR, "Reliability of fine-needle aspiration in patients with familial nonmedullary thyroid cancer" 9 : 1011-1016, 1999

8 Frates MC, "Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography" 91 : 3411-3417, 2006

9 Charkes ND, "On the prevalence of familial nonmedullary thyroid cancer" 8 : 857-858, 1998

10 Kim EK, "New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid" 178 : 687-691, 2002

11 Frates MC, "Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement" 237 : 794-800, 2005

12 Rago T, "Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fineneedle aspiration cytology in a large series of patients with nodular thyroid disease" 162 : 763-770, 2010

13 Schneider AB, "Long-term risks for thyroid cancer and other neoplasms after exposure to radiation" 1 : 82-91, 2005

14 Mazzaferri EL, "Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer" 97 : 418-428, 1994

15 Barroeta JE, "Is fine-needle aspiration (FNA) of multiple thyroid nodules justified?" 17 : 61-65, 2006

16 Alsanea O, "Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series" 128 : 1043-1050, 2000

17 Moore FD Jr, "Inherited aspects of papillary thyroid carcinoma" 94 : 719-724, 2006

18 Mazeh H, "In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease" 22 : 3-8, 2012

19 Kumar H, "Gender, clinical findings, and serum thyrotropin measurements in the prediction of thyroid neoplasia in 1005patients presenting with thyroid enlargement and investigated by fine-needle aspiration cytology" 9 : 1105-1109, 1999

20 Amir A, "Gender as a risk factor of malignancy in a thyroid nodule" 143 (143): P61-, 2010

21 Franklyn JA, "Fine needle aspiration cytology in diffuse or multinodular goitre compared with solitary thyroid nodules" 307 : 240-, 1993

22 Alsanea O, "Familial thyroid cancer" 13 : 44-51, 2001

23 Hemminki K, "Familial risks for nonmedullary thyroid cancer" 90 : 5747-5753, 2005

24 McDonald TJ, "Familial papillary thyroid carcinoma: a retrospective analysis" 2011 : 948786-, 2011

25 Hillenbrand A, "Familial nonmedullary thyroid carcinomaclinical relevance and prognosis. A European multicenter study. ESES Vienna presentation" 395 : 851-858, 2010

26 Malchoff CD, "Familial nonmedullary thyroid carcinoma" 13 : 106-110, 2006

27 Mazeh H, "Familial nonmedullary thyroid carcinoma" 23 : 1049-1056, 2013

28 Khan A, "Familial nonmedullary thyroid cancer: a review of the genetics" 20 : 795-801, 2010

29 Capezzone M, "Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity" 15 : 1075-1081, 2008

30 Choi JS, "Evaluation of serum thyroid-stimulating hormone as indicator for fine-needle aspiration in patients with thyroid nodules" 37 : 498-504, 2015

31 Ferlay J, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008" 127 : 2893-2917, 2010

32 Triponez F, "Does familial non-medullary thyroid cancer adversely affect survival?" 30 : 787-793, 2006

33 Iribarren C, "Cohort study of thyroid cancer in a San Francisco Bay area population" 93 : 745-750, 2001

34 Tuttle RM, "Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration" 8 : 377-383, 1998

35 Vriens MR, "Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer" 19 : 1343-1349, 2009

36 Belfiore A, "Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity" 93 : 363-369, 1992

37 Moon WJ, "Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study" 247 : 762-770, 2008

38 Bouhabel S, "Are solitary thyroid nodules more likely to be malignant?" 41 : 119-123, 2012

39 Sippel RS, "An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up" 31 : 924-933, 2007

40 Gharib H, "American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules" 12 : 63-102, 2006